Biomarkers immune monitoring technology primer: Immunoscore® Colon
نویسنده
چکیده
Abbreviations: CC, Colon cancer; CRC, Colorectal cancer; CT, Core of the tumor; DAB, Diaminobenzidine; DFS, Disease-free-survival; DP, Digital pathology; DSS, Disease-specific-survival; FFPE, Formalin-fixed paraffin-embedded; IHC, Immunohistochemistry; IM, Invasive margin; INSERM, Institut national de la santé et de la recherche médicale; IS, Immunoscore; IVD, In vitro diagnostic; MSI, Microsatellite instable; MSS, Microsatellite stable; OS, Overall survival; QC, Quality control; ROI, Region of interest; RUO, Research use only; SITC, Society for immunotherapy of cancer; TNM, Tumor burden/ lymph nodes/ metastases
منابع مشابه
Immunoregulation and genotype in colorectal cancer
Classical methods for determining malignant disease prognosis are based upon characterizing the morphology and location of tumor cells. While this analysis provides important information about a patient’s disease it fails to capture the biological complexity of the tumor microenvironment and the contribution of the anti-tumor immune response. Basic histological quantification of T lymphocyte de...
متن کاملImmune monitoring technology primer: clinical validation for predictive markers
Background: Recent biotechnological developments have resulted in increasing interest in immunology biomarkers. These biomarkers have potential clinical utility in the near future as predictors of treatment response. Hence, clinical validation of these predictive markers is critical. Findings: The process of clinically validating a predictive biomarker is reviewed. Validation of a predictive bi...
متن کاملImmune monitoring technology primer
BACKGROUND Recent biotechnological developments have resulted in increasing interest in immunology biomarkers. These biomarkers have potential clinical utility in the near future as predictors of treatment response. Hence, clinical validation of these predictive markers is critical. FINDINGS The process of clinically validating a predictive biomarker is reviewed. Validation of a predictive bi...
متن کاملImmunoscore: a new possible approach for melanoma classification
Background Increasing evidence has supported the hypothesis that cancer development is influenced by the host immune system. The number, type and location of the immune cells infiltrating the tumor microenvironment (TILs) may either limit or promote tumor progression [1]. These observations have led to the development of potential new scoring systems derived from the immune context in tissue an...
متن کاملImmunoscore® as a predictor of response to chemotherapy in stage II and stage III colon cancer
Background No biomarker has been validated so far to predict the need for adjuvant chemotherapy in Stage II colon cancer (CC), and current guidelines, e.g. NCCN, only rely on the identification of high-risk features such as MSI, pathological tumor characteristics or expected chemotherapy efficacy/safety ratio in each individual patient. In contrast, adjuvant chemotherapy is recommended for all ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 4 شماره
صفحات -
تاریخ انتشار 2016